Search research articles
Contact Us
Filters
Showing results (161-170 of 169) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 169 results.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 24, 2024
Performance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Primary Prevention Indications: A Prospective Observational Cohort Study
Yaodong Li, Yangxin Chen, Jingfeng Wang, et al.
Neurology
|
April 24, 2021
New Model for Estimation of the Age at Onset in Spinocerebellar Ataxia Type 3
Linliu Peng, Zhao Chen, Zhe Long, et al.
Frontiers in Aging Neuroscience
|
July 22, 2022
The Natural History of Spinocerebellar Ataxia Type 3 in Mainland China: A 2-Year Cohort Study
Yun Peng, Linliu Peng, Zhao Chen, et al.
Neurobiology of Disease
|
June 7, 2026
The fT3/fT4 ratio as a candidate marker of motor progression in SCA3
Mengyuan Dong, Ziyan Ding, Zhao Chen, et al.
Frontiers in Pharmacology
|
July 2, 2025
Tricin selectively combats KRAS-mutant non-small cell lung cancer by inhibiting the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway and potentiating the antitumor effect of an anti-PD-1 antibody
Jia-Xin Li, Shi-Yu Tan, Li-Qi Li, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 6, 2023
Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by SV2A Positron Emission Tomography
Zhao Chen, Guang Liao, Na Wan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 29, 2020
Prediction of the Age at Onset of Spinocerebellar Ataxia Type 3 with Machine Learning
Linliu Peng, Zhao Chen, Tiankai Chen, et al.
Lancet (London, England)
|
May 29, 2026
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
Anwen Xiong, Wenxiu Yao, Wei Zheng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2026
Intravenous Patient-Controlled Analgesia Versus Oral Opioids to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase III Trial
Rongbo Lin, Lang He, Mingqian Lu, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 169) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 169 results.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 24, 2024
Performance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Primary Prevention Indications: A Prospective Observational Cohort Study
Yaodong Li, Yangxin Chen, Jingfeng Wang, et al.
Neurology
|
April 24, 2021
New Model for Estimation of the Age at Onset in Spinocerebellar Ataxia Type 3
Linliu Peng, Zhao Chen, Zhe Long, et al.
Frontiers in Aging Neuroscience
|
July 22, 2022
The Natural History of Spinocerebellar Ataxia Type 3 in Mainland China: A 2-Year Cohort Study
Yun Peng, Linliu Peng, Zhao Chen, et al.
Neurobiology of Disease
|
June 7, 2026
The fT3/fT4 ratio as a candidate marker of motor progression in SCA3
Mengyuan Dong, Ziyan Ding, Zhao Chen, et al.
Frontiers in Pharmacology
|
July 2, 2025
Tricin selectively combats KRAS-mutant non-small cell lung cancer by inhibiting the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway and potentiating the antitumor effect of an anti-PD-1 antibody
Jia-Xin Li, Shi-Yu Tan, Li-Qi Li, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 6, 2023
Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by SV2A Positron Emission Tomography
Zhao Chen, Guang Liao, Na Wan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 29, 2020
Prediction of the Age at Onset of Spinocerebellar Ataxia Type 3 with Machine Learning
Linliu Peng, Zhao Chen, Tiankai Chen, et al.
Lancet (London, England)
|
May 29, 2026
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
Anwen Xiong, Wenxiu Yao, Wei Zheng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2026
Intravenous Patient-Controlled Analgesia Versus Oral Opioids to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase III Trial
Rongbo Lin, Lang He, Mingqian Lu, et al.
Page
of 17